Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The protein encoded by TNFRSF17 is a member of the TNF-receptor superfamily. Zusätzlich bieten wir Ihnen TNFRSF17 Proteine (52) und TNFRSF17 Kits (19) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 126 products:
Human Polyclonal TNFRSF17 Primary Antibody für ELISA (Detection), FACS - ABIN4899163
Moir, Malaspina, Pickeral, Donoghue, Vasquez, Miller, Krishnan, Planta, Turney, Justement, Kottilil, Dybul, Mican, Kovacs, Chun, Birse, Fauci: Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. in The Journal of experimental medicine 2004
Show all 5 Pubmed References
Mouse (Murine) Monoclonal TNFRSF17 Primary Antibody für FACS - ABIN4895658
Notley, Baker, Ehrenstein: Secreted IgM enhances B cell receptor signaling and promotes splenic but impairs peritoneal B cell survival. in Journal of immunology (Baltimore, Md. : 1950) 2010
Show all 5 Pubmed References
Human Monoclonal TNFRSF17 Primary Antibody für BP, ELISA - ABIN4283793
Sakurai, Hase, Kanno, Kojima, Okumura, Kobata: TACI regulates IgA production by APRIL in collaboration with HSPG. in Blood 2007
Show all 3 Pubmed References
Human Polyclonal TNFRSF17 Primary Antibody für FACS - ABIN4895686
Frigyesi, Adolfsson, Ali, Christophersen, Johnsson, Turesson, Gullberg, Hansson, Nilsson: Robust isolation of malignant plasma cells in multiple myeloma. in Blood 2014
Show all 2 Pubmed References
Human Monoclonal TNFRSF17 Primary Antibody für FACS - ABIN4255822
Lyu, Rai, Ahn, Sung, Cheung, Marks, Aggarwal, Aguiar, Gandhi, Rosenblum: The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo. in Neoplasia (New York, N.Y.) 2010
Show all 2 Pubmed References
Human Polyclonal TNFRSF17 Primary Antibody für FACS - ABIN4895684
Bloom, Chang, Pauly, Kwun, Fechner, Hayes, Samaniego, Knechtle: BAFF is increased in renal transplant patients following treatment with alemtuzumab. in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009
Mouse (Murine) Monoclonal TNFRSF17 Primary Antibody für BP, FACS - ABIN4283791
Hardenberg, Fernandez, Hendriks, Chebli, Jacquet, Sitbon, Hahne, Medema: APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis. in Journal of leukocyte biology 2008
BCMA has other contributors for ligands binding except DxL motif. The affinity of BCMA for APRIL higher than for BAFF (zeige TNFSF13B Antikörper) may be caused by the segment outside of the conservative DxL motif. Moreover, the exposition of new binding modes of BCMA2 interacting with APRIL may establish the foundation of designing novel drugs in the future
New molecular mechanisms of in vivo Multiple Myeloma (MM) growth and immunosuppression critically dependent on BCMA and APRIL in the Bone marrow microenvironment, further supporting targeting this prominent pathway in MM.
We have identified a specific serum protein, BCMA, as a novel independent marker for both monitoring and predicting outcomes for MM patients. We have shown that sBCMA is elevated in MM patients, and can be used to follow their disease status, PFS and OS.
The expression levels of serum BAFF (zeige TNFSF13B Antikörper) and the three receptors (TACI (zeige TNFRSF13B Antikörper), BCMA and BAFF-R (zeige TNFRSF13C Antikörper)) in non-Hodgkin lymphoma patients were significantly higher than in healthy controls.
Decreased BCMA expression on peripheral B cells according to severe disease activity suggests that BCMA plays an important regulating role in B-cell hyperactivity and immune tolerance homeostasis in systemic lupus erythematosus patients
results suggest that Akt (zeige AKT1 Antikörper) and JNK (zeige MAPK8 Antikörper) pathways are involved in the regulation of B-cell maturation antigen (BCMA)
shedding of BCMA by gamma-secretase controls plasma cells in the bone marrow and yields a potential biomarker for B-cell involvement in human autoimmune diseases
Data show significant differences in expression of tumour necrosis factor (zeige TNF Antikörper) family (BAFF (zeige TNFSF13B Antikörper)) receptors BAFF-R (zeige TNFRSF13C Antikörper), BCMA and TACI (zeige TNFRSF13B Antikörper) in patients with and without anti-Jo-1 or anti-Ro52 (zeige TRIM21 Antikörper)/anti-Ro60 (zeige TROVE2 Antikörper) autoantibodies.
High BCMA expression is associated with breast cancer.
BAFF (zeige TNFSF13B Antikörper) and APRIL as well as their cognate receptors (BCMA, TACI (zeige TNFRSF13B Antikörper)) correlate with glioma grade. (Meta-analysis)
high affinity antibody blocks the binding of the native ligands APRIL and BAFF (zeige TNFSF13B Antikörper) to BCMA. This finding is rationalized by the high resolution crystal structure of the Fab (zeige FANCB Antikörper) fragment in complex with the extracellular domain of BCMA
Elimination of B lymphocyte stimulator (zeige TNFSF13B Antikörper) receptor 3 (BR-3) and BCMA inhibits the development of SLE in NZM mice.
we have identified a novel role for BCMA to control excess BAFF (zeige TNFSF13B Antikörper) production in murine lupus through restraining the accumulation of BAFF (zeige TNFSF13B Antikörper)-producing neutrophils.
Heteromers consisting of one BAFF (zeige TNFSF13B Antikörper) and two APRIL bind to receptor TACI (zeige TNFRSF13B Antikörper), BCMA but not to BAFFR (zeige TNFRSF13C Antikörper).
BCMA is dispensable for the development of SLE in NZM mice. BAFF (zeige TNFSF13B Antikörper)-BCMA interactions contribute to SLE.
Study reveals that BCMA works to control B cell homeostasis and self-tolerance in systemic autoimmunity.
Blimp-1 (zeige PRDM1 Antikörper) is a positive regulator of the expression of BCMA gene in mouse plasma cells.
The 5'-flanking sequence from -820 to +145 bp of BCMA is of promoter activity.
A vital role of BCMA in bone marrow plasma cell survival.
B cell maturation antigen, the receptor for a proliferation-inducing ligand (zeige TNFSF13 Antikörper) and B cell-activating factor (zeige TNFSF13B Antikörper) of the TNF (zeige TNF Antikörper) family, induces antigen presentation in B cells.
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation.
tumor necrosis factor receptor superfamily member 17
, tumor necrosis factor receptor superfamily, member 17
, B cell maturation antigen
, B-cell maturation factor
, B-cell maturation protein